Shares are up 7% in trading today, after Geron announced a strategic restructuring to "position the company for long-term ...
Beyond blood cancers, GT Biopharma is developing GTB-5550, which targets B7H3, a protein commonly found across various solid tumor types including breast, lung, ovarian, pancreatic, bladder, and ...